Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Virginia F. Borges

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Borges, Virginia

One or more keywords matched the following items that are connected to Borges, Virginia

Item Type	Name
Academic Article	A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
Academic Article	Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.
Academic Article	BRCA in breast cancer: from risk assessment to therapeutic prediction.
Academic Article	The era of high-dose chemotherapy for breast cancer: revisiting a troubled quest.
Academic Article	A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
Academic Article	Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women.
Academic Article	Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
Academic Article	Molecularly targeted therapy: when to stop and when to continue?
Academic Article	Fulvestrant: a unique antiendocrine agent for estrogen-sensitive breast cancer.
Concept	Antineoplastic Agents
Concept	Antineoplastic Agents, Hormonal
Academic Article	Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.
Academic Article	Management of young breast cancer patients with de novo genetic mutations.
Academic Article	Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention.
Academic Article	Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
Academic Article	A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.
Academic Article	A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Academic Article	Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.
Academic Article	Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning.
Concept	Antineoplastic Agents, Immunological
Academic Article	Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
Academic Article	Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Academic Article	Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer.
Academic Article	NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Academic Article	Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
Academic Article	Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy.
Academic Article	Options for Endocrine-Refractory, Hormone Receptor-Positive Breast Cancer: Which Target and When?
Academic Article	Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer.
Academic Article	Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.

Search Criteria

Antineoplastic Agents